DXYN: the cash flow

MyFinsight

For the year ending 2025-12-27, DXYN had $7,050K increase in cash & cash equivalents over the period.

Cash Flow	2025-12-27
Loss from continuing operations	-7,275
Depreciation and amortization	5,620
Net gain loss on property, plant and equipment disposals	95
Impairment of assets	0
Stock-based compensation expense	240
Expense for expected credit losses	274
Loss on extinguishment of debt	-66
Receivables	-67
Inventories	-482
Prepaid and other current assets	-252
Accounts payable and accrued expenses	9,339
Other operating assets and liabilities	-659
Net cash provided by operating activities	9,629
Net cash used in operating activities - discontinued operations	-488
Net proceeds from sales of property, plant and equipment	125
Purchase of property, plant and equipment	598
Joint venture capital distributions	0
Net cash used in investing activities	-473
Net borrowings (payments) on previous revolving credit facility	-50,000
Borrowings on current revolving credit facility	292,775
Payments on current revolving credit facility	240,069
Payments on notes payable - buildings and other term loans	2,138
Borrowings on notes payable - other	1,513
Payments on notes payable - other	1,793
Payments on finance leases	152
Change in outstanding checks in excess of cash	-456
Repurchases of common stock	27
Payments for debt issuance costs	1,271
Net cash used in financing activities	-1,618
Increase (decrease) in cash, cash equivalents and restricted cash	7,050
Cash, cash equivalents and restricted cash at beginning of period	19
Cash, cash equivalents and restricted cash at end of period	7,069

Unit: Thousand (K) dollars (except for numbers of shares and EPS).